Clinical Trial Update: Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of combined irbesartan and amlodipine therapy in essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• irbesartan + amlodipine combination

Snippet

Sponsor: Handok Inc. | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED